Aerie doses first patient in COMET-3 study for DED treatment
August 2, 2022, by: Alex Delaney-Gesing, Senior Editor COMET-3 is the second of 3 studies in the AR-15512 Registrational Phase 3 Program, which is slated for completion by 2023. Aerie…
August 2, 2022, by: Alex Delaney-Gesing, Senior Editor COMET-3 is the second of 3 studies in the AR-15512 Registrational Phase 3 Program, which is slated for completion by 2023. Aerie…